Source: Osha.gov | Receipt Date: 2021-02-11
Mayodan, North Carolina, United States
Updated:
Source: Osha.gov | Receipt Date: 2021-02-11
Report: 4/08/2020
Source: www.greensboro.com
Recent Interesting Reports
Heather motttsy, NYC, NY, USA
3 weeks ago •reported by user-ntxgn253
Ordered The same cross took 4. Maybe 5 weeks just got the box. And it's in like 20 pieces that I'm supposed to put together. No good these people are a*******
Okay.
Not the same as advertised, New Orleans, LA, USA
1 week ago •reported by user-ybpyc327
Unauthorized Credit Card Charge from Peggy Piercy, Virginia Beach, VA, USA
3 weeks ago •reported by user-cfjm3464
A product scam, 2207 Summit Ave, Union City, NJ, USA
3 weeks ago •reported by user-fznt6631
I did not order, Oregon, OH, USA
1 week ago •reported by user-yxpqq462
Foveth thought it was judy blue jeans, Foveth
1 week ago •reported by user-zfkjc166
Yealdeals is a fake best buy, Mountain Home, Arkansas, USA
1 week ago •reported by user-tpkqm326
AvKARE, LLC Atovaquone Oral Suspension - recalled due to potential Bacillus cereus contamination, USA
3 weeks ago •source www.fda.gov
Recall notice
Risk Statement: In the population most at risk, immunocompromised population, there is a reasonable probability that microbial contamination of Atovaquone Oral Suspension can result in disseminated, life threatening infections such as endocarditis and necrotizing soft tissue infections.
Atovaquone Oral Suspension, USP is indicated for prevention and treatment of Pneumocystis jiroveci pneumonia (PCP) in adults and children 13 years of age and older who cannot tolerate other medicines, such as trimethoprim-sulfamethoxazole.
The product is packaged in a carton. The identified NDC # associated with the product is 50268-086-12, UPC # 5026808612 and the affected lot# is AW0221A with an expiration date of 08/2025.
AvKARE, LLC is notifying its distributors and wholesale customers by mailings and email communications method and is arranging for returns of all recalled Atovaquone Oral Suspension, USP. Wholesalers who have Atovaquone Oral Suspension, USP 750mg/5mL, which are being recalled, should examine their inventory and cease dispensing, return any of the impacted lots to AvKARE, LLC. Consumers that have product which is being recalled should stop using the product and return it to place of purchase.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: AvKARE, LLC
Brand name: AVpak
Product recalled: Atovaquone Oral Suspension, USP 750mg/5mL
Reason of the recall: Potential Bacillus cereus contamination
FDA Recall date: April 01, 2024
Source: www.fda.gov
Did not order., Merritt Island, FL, USA
2 weeks ago •reported by user-qdfdj275
I ordered a sweatshirt and got a amarata jacket, Bucuresti ,str Aleea Lunca Siretului,nr 1A,sector 6
3 weeks ago •reported by user-ydfg4319
Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com